Navigation Links
United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
Date:8/9/2011

(CMF), United Kingdom, Company Share (2009-2010) 84

6 Joint Reconstruction In United Kingdom 86

6.1 Joint Reconstruction, Market Segmentation 86

6.2 Joint Reconstruction Market, United Kingdom, Revenue Mix ($m), 2010 87

6.3 Joint Reconstruction Market, United Kingdom, Segment Contribution (%), 2010 88

6.4 Joint Reconstruction Overall Revenue (2003-2017) 89

6.4.1 Hip Replacement Revenue (2003-2017) 93

6.4.2 Knee Replacement Revenue (2003-2017) 97

6.4.3 Shoulder Replacement Revenue (2003-2017) 101

6.5 Joint Reconstruction Overall Volume (2003-2017) 105

6.5.1 Hip Replacement Volume (2003-2017) 109

6.5.2 Knee Replacement Volume (2003-2017) 113

6.5.3 Shoulder Replacement Volume (2003-2017) 117

6.6 Joint Reconstruction Average Price (2003-2017) 121

6.7 Joint Reconstruction Distribution Share (2009-2010) 123

6.8 Joint Reconstruction, United Kingdom, Company Share (2009-2010) 124

7 Orthobiologics In United Kingdom 126

7.1 Orthobiologics, Market Segmentation 126

7.2 Orthobiologics Market, United Kingdom, Revenue Mix ($m), 2010 127

7.3 Orthobiologics Market, United Kingdom, Segment Contribution (%), 2010 128

7.4 Orthobiologics Overall Revenue (2003-2017) 129

7.4.1 Bone Graft Substitutes Revenue (2003-2017) 133

7.5 Orthobiologics Overall Volume (2003-2017) 137

7.5.1 Bone Graft Substitutes Volume (2003-2017) 141

7.6 Orthobiologics Average Price (2003-2017) 145

7.7 Orthobiologics Distribution Share (2009-2010) 146

7.8 Orthobiologics, United Kingdom, Company Share (2009-2010) 147

8 Orthopedic Accessories In United Kingdom 149

8.1 Orthopedic Accessories, Market Segmentation 149

8.2 Orthopedic Accessories Market, United Kingdom, Revenue Mix ($m), 2010 150

8.3 Orthopedic Accessories Market, United Kingdom, Segment Contribution (%), 2010 151

8.4 Orthopedic Accessories Ov
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. R-CALF United Stockgrowers of America: Fighting for the U.S. Cattle Producer
3. United States, Canada and Mexico Agree to Mutual Assistance During Public Health Emergencies
4. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
5. Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
6. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
7. American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule
8. Premier Research Expands its Medical Device Operations to the United States
9. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
10. United States Patent and Trademark Office Publishes Stemedicas Patent Application for the Treatment of Diabetic Retinopathy
11. EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today ... company at the Morgan Stanley Global Healthcare Conference in ... Tuesday September 9, 2014 , Presentation time: 5:15 p.m. ... archive of this presentation will be available at http://ir.avanir.com ... Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing ...
(Date:9/2/2014)... 2014  Edison Nation Medical, the premier healthcare ... American Association for Respiratory Care ( AARC ), ... Edison Nation Medical, which brings 12+ years experience ... their innovation ideas, will work with AARC to ... 50,000 respiratory therapists in bringing their product innovation ...
(Date:9/2/2014)... Today, Analysts Review released its ... ), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR ), ... (NYSE: SNY ) and GlaxoSmithKline plc (NYSE: ... publication. To reserve complementary membership, limited openings are available ... Reports ,WellPoint Inc. (WellPoint) posted on the Events and ...
Breaking Medicine Technology:Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 3Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 2Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 3Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 4Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 5Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 6
... 2011 Fuisz ( www.fuisz.com ) today announced the ... Permitting Stage Door Access to On-Line Vendor Information"). ... "This patent covers a system that allows a customer ... a product supplier database through the on-line vendor,s system ...
... 15, 2011 Cardium Therapeutics (NYSE Amex: ... from the Russian Ministry of Health and Social Development ... Company,s Generx™ (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.  Generx ... for the potential treatment of myocardial ischemia due to ...
Cached Medicine Technology:Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 2Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 3Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 4Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 5Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 6Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 7
(Date:9/2/2014)... in California, the percentage undergoing a double mastectomy increased ... not associated with a lower risk of death than ... the September 3 issue of JAMA . The ... one breast was associated with a higher risk of ... , Randomized trials have demonstrated similar survival for patients ...
(Date:9/2/2014)... cancer cells can lay the groundwork for their own ... vessels to send out tumor-welcoming signals, according to a ... the Sept. 2 issue of Nature Communications , ... increased levels of so-called signaling molecules released by breast ... in the lungs and lymph nodes to produce proteins ...
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... (PRWEB) September 03, 2014 Operators in ... to millions of people annually, arranging care and counsel ... and private enterprises are expected to derive $39.4 billion ... donations and private income. Over the five years through ... annualised rate of 6.6%, including growth of 4.1% in ...
(Date:9/2/2014)... new studies further confirm the health benefits of breast-feeding. ... a lower risk of ear, throat and sinus infections ... similar trend when it comes to allergies. The ... immediate newborn period," said Dr. Jennifer Wu, an obstetrician-gynecologist ... was not involved in the new studies. The ...
Breaking Medicine News(10 mins):Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... of "color-coded" laboratory mice are providing researchers with a ... and monitor the cellular immune responses of transplanted tissue ... in the June issue of Nature Medicine , ... are a key consideration in developing strategies to improve ...
... release is available in Spanish . , ... , from the Department of Physiology of the University ... Castillo Garzn . To carry out this project, the researcher ... and Assessment of Nutritional Status of Spanish Adolescents) and HELENA ...
... ... Cancer joins Cyberknife of Long Island , ... (PRWEB) May 27, 2010 -- Cyberknife of Long Island treats tumors ... Accuray offers unprecedented capabilities and renewed hope to prostate cancer patients. Cyberknife ...
... sex, still urged, experts say, , THURSDAY, May 27 (HealthDay ... for transmitting the virus to their partners by 90 percent ... Antiretroviral drug therapy helps reduce HIV levels in the infected ... to others. The drugs are commonly taken in the United ...
... in end-stage cardiac patients has a significantly lower risk for ... researchers at Henry Ford Hospital in Detroit. Known as ... HeartMate ,is much smaller than the first and uses a ... itself, to continually push blood through the body. Its predecessor ...
... ... no longer have access to per incident technical support services , ... (PRWEB) May 27, 2010 -- In a recent announcement ... Avaya maintenance agreement will no longer have access to per incident technical support services which ...
Cached Medicine News:Health News:Color-coded tracking method helps scientists analyze outcomes of newly transplanted tissue 2Health News:Color-coded tracking method helps scientists analyze outcomes of newly transplanted tissue 3Health News:Researchers validate a new test for assessing children's and teenagers' fitness to prevent morbidity 2Health News:Cyberknife of Long Island Destroys Prostate Cancer Non-Invasively Using Radiosurgery 2Health News:Cyberknife of Long Island Destroys Prostate Cancer Non-Invasively Using Radiosurgery 3Health News:Anti-HIV Drugs May Help Prevent Spread of Virus 2Health News:Henry Ford Hospital study: Fewer infections with new heart-pump implant 2Health News:Avaya Announces End of Support to Non Maintenance Customers 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: